Image Source: Global Prime News
Neogen Chemicals reported consolidated revenue from operations of 2.20 billion rupees in Q3 FY26, reflecting strong topline growth. However, consolidated profit stood at 36.9 million rupees, indicating margin pressures. The company also announced a preferential issue of equity shares worth 150 crore rupees and new ESOP grants.
Show more
Neogen Chemicals Limited has released its Q3 FY26 financial results, showcasing robust revenue growth but a decline in profitability. The board also approved strategic capital-raising measures and employee stock option plans to strengthen future operations.
Key Highlights
-
Revenue from operations reached 2.20 billion rupees, underscoring strong demand across specialty chemical segments
-
Consolidated profit after tax stood at 36.9 million rupees, reflecting margin pressures despite revenue growth
-
Operating profit was reported at 275.4 million rupees, with total income at 2.22 billion rupees
-
The board approved raising up to 150 crore rupees via a preferential issue of equity shares, primarily backed by promoter group intent
-
A new tranche of 50,200 stock options was sanctioned under the 2024 ESOP scheme, reinforcing employee participation
-
Market performance showed volatility, with Neogen’s stock trading between 978 and 2,186 rupees over the past 52 weeks, reflecting investor caution amid earnings pressure
Sources: Mint, Moneycontrol, Invest
Stay Ahead – Explore Now!
Stability in Energy: Fitch Reaffirms Credit Strength of 13 APAC Oil & Gas Firms
Advertisement
STORIES YOU MAY LIKE
Image Source: FINIEN
Updated: February 11, 2026 18:03
Image Source: Business in Vancouver
Updated: February 10, 2026 19:08
Image Source: Inside Osaka
Updated: February 09, 2026 17:00
Advertisement